A Computational Perspective on Drug Discovery and Signal Transduction Mechanism of Dopamine and Serotonin Receptors in the Treatment of Schizophrenia

Publisher： Bentham Science Publishers

E-ISSN： 1873-4316|15|10|916-926

ISSN： 1389-2010

Source： Current Pharmaceutical Biotechnology, Vol.15, Iss.10, 2014-10, pp. : 916-926

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dopamine Receptor Pharmacology: Interactions with Serotonin Receptors and Significance for the Aetiology and Treatment of Schizophrenia

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 5, Iss. 1, 2006-02 ,pp. : 3-23

Bentham Science Publishers

Access to resources Recommend Favorite

Signal Transduction Pathway Targets for Anticancer Drug Discovery

By  

Current Pharmaceutical Design, Vol. 6, Iss. 4, 2000-03 ,pp. : 361-378

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Developments in the Discovery of Novel Antipsychotic Agents Modualating Dopamine and Serotonin Receptors

By  

Current Drug Targets, Vol. 14, Iss. 8, 2013-07 ,pp. : 899-918

Bentham Science Publishers

Access to resources Recommend Favorite

Absence of detectable striatal dopamine D 4 receptors in drug-treated schizophrenia

By Reynolds G.P.   Mason S.L.  

European Journal of Pharmacology, Vol. 281, Iss. 2, 1995-08 ,pp. : 5-6

Elsevier

Access to resources Recommend Favorite

Targeted D4 Dopamine Receptors: Implications for Drug Discovery and Therapeutic Development

By  

Current Drug Targets, Vol. 14, Iss. 4, 2013-04 ,pp. : 507-512

Bentham Science Publishers

Access to resources Recommend Favorite